Better Therapeutics, Inc. is a San Francisco-based company that develops software-based prescription digital therapeutics to treat diabetes, heart disease, and other cardiometabolic conditions. Its lead product candidate, BT-001, uses digitally delivered Nutritional Cognitive Behavioral Therapy to treat type 2 diabetes. Better Therapeutics also has products in development that help patients with hypertension and hyperlipidemia, which are BT-002 and BT-003, respectively.